Professional China DL-Mandelic Acid 90-64-2 - Ibutamoren mesylate 214962-40-0 Hormone and endocrine – Neore
Professional China DL-Mandelic Acid 90-64-2 - Ibutamoren mesylate 214962-40-0 Hormone and endocrine – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 60kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool and dry place, sealed and keep away from light.
Package material:drum
Package size:25kg/drum
Safety information: Not dangerous goods
Introduction
Ibutamoren mesylate, also named MK677, is a potent, long-acting, orally-active, selective, and non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue, mimicking the growth hormone (GH)-stimulating action of the endogenous hormone ghrelin. It has been shown to increase the secretion of several hormones including GH and insulin-like growth factor 1 (IGF-1) and produces sustained increases in the plasma levels of these hormones without affecting cortisol levels.
Specification (in house standard)
Item |
Specification |
Appearance | White to off-white powder |
1HNMR | Conforms to structure |
LC-MS | [M-Methanesulfonicacid+H]+:(530.1-530.2) |
Loss on Drying | ≤0.50% |
Residue on Ignition | ≤0.10% |
Heavy Metal | <10ppm |
Purity by HPLC | ≥99.0% |
Product detail pictures:

Related Product Guide:
carry on to further improve, to guarantee merchandise high-quality in line with market and buyer standard necessities. Our organization has a top quality assurance procedure have already been established for Professional China DL-Mandelic Acid 90-64-2 - Ibutamoren mesylate 214962-40-0 Hormone and endocrine – Neore , The product will supply to all over the world, such as: Netherlands, Somalia, Sweden, Providing Quality Products, Excellent Service, Competitive Prices and Prompt Delivery. Our products are selling well both in domestic and foreign markets. Our company is trying to be one important suppliers in China.

Managers are visionary, they have the idea of "mutual benefits, continuous improvement and innovation", we have a pleasant conversation and Cooperation.
